🚨 Excited: Our paper in @JACCJournals on #Myocarditis"!
🔍 We compared Myo-criteria in 1,557 undergoing #whyCMR🧲
❗️89%#ESC, 29%#LLC
❗️LLC➡️event rates (6.6%/yr)
❗️Negative ESC➡️great prognosis (0.7%yr)
💡 ESC & LLC complement diagnosis & risk sciencedirect.com/science/articl…
🔍 We compared Myo-criteria in 1,557 undergoing #whyCMR🧲
❗️89%#ESC, 29%#LLC
❗️LLC➡️event rates (6.6%/yr)
❗️Negative ESC➡️great prognosis (0.7%yr)
💡 ESC & LLC complement diagnosis & risk sciencedirect.com/science/articl…